Efficacy of stress-response protease-deficient Salmonella enterica serovar Typhimurium as a candidate of live oral vaccine strain
应激反应蛋白酶缺陷型鼠伤寒沙门氏菌作为候选活口服疫苗株的功效
基本信息
- 批准号:15590398
- 负责人:
- 金额:$ 1.92万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The Lon protease-deficient Salmonella enterica serovar Typhimurium (CS2022) is immunogenic when given via the oral infection route in mice. In the present study, CS2022 continuously resided in the spleen of BALB/c mice with less than 10^2 CFU for up to 6 weeks after a single oral inoculation with 10^7 CFU of salmonellae. A significant increase in the serovar Typhimurium lipopolysaccharide (LPS)-specific IgG2a was detected in the serum at weeks 4, 6, and 13 after inoculation. In contrast, the LPS-specific IgG1 was detectable at weeks 6 and 13 after inoculation. The expression of IFN-γ mRNA in the spleens of these mice was significantly increased at weeks 4 and 6 after inoculation. In contrast, the expression of IL-4 mRNA was increased at week 6 after inoculation. As a result, oral inoculation with CS2022 protected mice against subsequent subcutaneous challenge with the virulent serovar Typhimurium. In addition, the inoculation was able to reduce the colonization of Listeria monocytogenes in the livers for at least 6 weeks after inoculation when it was administered via the subcutaneous infection route. Furthermore, peritoneal macrophages isolated from immunized mice at weeks 2, 4, and 6 after inoculation led to an increase in the intracellular killing activity against L.monocytogenes as well as against serovar Typhimurium. These findings suggest that oral immunization with CS2022 promoted the protective innate immunity associated with macrophages, and this rapid protective immunity might also be sufficient to eliminate the colonization of certain intracellular pathogens other than Salmonella for at least 6 weeks after immunization of mice.
Lon蛋白酶缺陷型鼠伤寒沙门氏菌(CS2022)通过小鼠经口感染途径给药时具有免疫原性。在本研究中,单次经口接种10^7 CFU沙门氏菌后,CS2022以低于10^2 CFU持续驻留在BALB/c小鼠脾脏中长达6周。在接种后第4、6和13周,在血清中检测到鼠伤寒血清型脂多糖(LPS)特异性IgG 2a显著增加。相反,LPS特异性IgG 1在接种后6周和13周可检测到。免疫后4周和6周,小鼠脾脏IFN-γ mRNA的表达显著增加。而IL-4 mRNA的表达在接种后6周开始增加。因此,口服接种CS2022保护小鼠免受随后的皮下攻击与强毒血清型鼠伤寒。此外,当通过皮下感染途径给药时,接种能够在接种后至少6周内减少肝脏中单核细胞增生李斯特菌的定殖。此外,在接种后第2、4和6周从免疫小鼠中分离的腹腔巨噬细胞导致对单核细胞增生李斯特菌以及鼠伤寒血清型的细胞内杀伤活性增加。这些发现表明,口服免疫CS2022促进了与巨噬细胞相关的保护性先天免疫,并且这种快速的保护性免疫也可能足以在小鼠免疫后至少6周内消除除沙门氏菌以外的某些细胞内病原体的定殖。
项目成果
期刊论文数量(102)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The DnaK/DnaJ chaperone machinery of Salmonella enterica serovar Typhimurium is essential for invasion of epithelial cells and survival in macrophages, leadin
鼠伤寒沙门氏菌的 DnaK/DnaJ 伴侣机制对于上皮细胞的侵袭和巨噬细胞的存活至关重要,
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:A.Takaya;T.Tomoyasu;H.Matsui;T.Yamamoto
- 通讯作者:T.Yamamoto
Interaction of leptin with gastric myofibroblast transdifferentiation in Helicobacter pylori-infected Mongolian gerbils : effect of rebamipide.
瘦素与幽门螺杆菌感染的蒙古沙鼠胃肌成纤维细胞转分化的相互作用:瑞巴派特的作用。
- DOI:
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:A.Takaya;T.Tomoyasu;H.Matsui;T.Yamamoto;M.Eguchi et al.;M.Nakamura et al.;M.Nakamura et al.;M.Nakamura et al.
- 通讯作者:M.Nakamura et al.
M.Eguchi, K.Monden, N.Miwa.: "Role of MAPK phosphorylation in cytoprotection by pro-Vrtamin C aganst oxidative stress-induced injuries in cultured cardiomyoblasts and perfused rat heart"J.Cell.Biochem.. 90・2. 219-226 (2003)
M.Eguchi、K.Monden、N.Miwa.:“MAPK 磷酸化在 Vrtamin C 前体细胞保护中的作用,对抗培养的成肌细胞和灌注大鼠心脏中氧化应激诱导的损伤”J.Cell.Biochem.. 90・2。 219-226 (2003)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Cytoprotection against ischemia-induced DNA cleavages and cell injuries in the rat liver by pro-vitamine C via hydrolytic conversion into ascorbate.
维生素原 C 通过水解转化为抗坏血酸,对大鼠肝脏中缺血诱导的 DNA 裂解和细胞损伤产生细胞保护作用。
- DOI:
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:A.Takaya;T.Tomoyasu;H.Matsui;T.Yamamoto;M.Eguchi et al.
- 通讯作者:M.Eguchi et al.
Mediators in Gastrointestinal Protection and Repair
胃肠道保护和修复的调节剂
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:M.Eguchi;T.Miyazaki;E.Masatsuji-Kato;T.Tsuzuki;T.Oribe;N.Miwa.;M.Nakamura et al.;M.Nakamura et al.
- 通讯作者:M.Nakamura et al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MATSUI Hidenori其他文献
MATSUI Hidenori的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MATSUI Hidenori', 18)}}的其他基金
Functional analysis of ROS signal regulator "RAM1" in plant defense
ROS信号调节器“RAM1”在植物防御中的功能分析
- 批准号:
25850034 - 财政年份:2013
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Functional analysis of a novel phosphorylation regulator in MAMPs signaling
MAMPs 信号传导中新型磷酸化调节因子的功能分析
- 批准号:
23780048 - 财政年份:2011
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Identification of the virulence factors associated with Helicobacter heilmannii-induced gastric MALT lymphoma
海尔曼螺杆菌诱发胃MALT淋巴瘤相关毒力因子的鉴定
- 批准号:
21590491 - 财政年份:2009
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Induction of cellular immunity by oral inoculation of attenuated Salmonella as a live vaccine vector
通过口服减毒沙门氏菌作为活疫苗载体诱导细胞免疫
- 批准号:
13670288 - 财政年份:2001
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
新生期接种乙肝疫苗(hepatitis B vaccine,HBV)影响小鼠情绪相关行为及其机制研究
- 批准号:31600836
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
Endoglin基因修饰肿瘤/DC杂交细胞诱生靶向特异性抗人肺癌CTL疫苗的研究
- 批准号:30760248
- 批准年份:2007
- 资助金额:16.0 万元
- 项目类别:地区科学基金项目
胰腺癌MUC4抗原多表位嵌合DNA疫苗的设计和免疫研究
- 批准号:30500492
- 批准年份:2005
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 1.92万 - 项目类别:
Research Grant
Development of a Cell-Based Assay for Tetanus Vaccine Quality Control
破伤风疫苗质量控制细胞检测方法的开发
- 批准号:
10101986 - 财政年份:2024
- 资助金额:
$ 1.92万 - 项目类别:
Collaborative R&D
Developing an infection-blocking pan-coronavirus vaccine
开发阻断感染的泛冠状病毒疫苗
- 批准号:
MR/Y019466/1 - 财政年份:2024
- 资助金额:
$ 1.92万 - 项目类别:
Research Grant
Vaccine hesitancy DAISI (Digital Animation in Service Improvement): To increase vaccine uptake in ethnic minority perinatal women and young children.
疫苗犹豫 DAISI(服务改进中的数字动画):提高少数民族围产期妇女和幼儿的疫苗接种率。
- 批准号:
MR/Z503964/1 - 财政年份:2024
- 资助金额:
$ 1.92万 - 项目类别:
Research Grant
Evolutionarily smart vaccine strain selection for proactive vaccinology
用于主动疫苗学的进化智能疫苗株选择
- 批准号:
MR/Y004337/1 - 财政年份:2024
- 资助金额:
$ 1.92万 - 项目类别:
Research Grant
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
- 批准号:
2420924 - 财政年份:2024
- 资助金额:
$ 1.92万 - 项目类别:
Standard Grant
Development of a mucosally-delivered and active salmon louse vaccine for Atlantic salmon aquaculture
开发用于大西洋鲑鱼水产养殖的粘膜递送活性鲑鱼虱疫苗
- 批准号:
BB/Y006534/1 - 财政年份:2024
- 资助金额:
$ 1.92万 - 项目类别:
Research Grant
Application of the virus-like particle (VLP) technology in the development of anti-tick vaccine, utilizing novel salivary proteins from Haemaphysalis longicornis ticks.
利用长角血蜱的新型唾液蛋白,应用病毒样颗粒(VLP)技术开发抗蜱疫苗。
- 批准号:
24K18027 - 财政年份:2024
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A novel self-adjuvanting vaccine platform
一种新型的自我辅助疫苗平台
- 批准号:
MR/Z503885/1 - 财政年份:2024
- 资助金额:
$ 1.92万 - 项目类别:
Research Grant
Developing bovine immune organoids for the screening of vaccine candidates
开发牛免疫类器官用于筛选候选疫苗
- 批准号:
NC/Y000889/1 - 财政年份:2024
- 资助金额:
$ 1.92万 - 项目类别:
Research Grant














{{item.name}}会员




